Dr Reddys Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹8,099.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.33 per cent from ₹7,546.40 crore. This corresponds to a year-on-year *(YoY) decline of 5.51 per cent.
Operating Profit
Operating Profit stands at ₹861.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.59 per cent from ₹640.00 crore. This corresponds to a year-on-year *(YoY) decline of 60.37 per cent.
PBDT
PBDT stands at ₹1,089.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 44.01 per cent from ₹756.80 crore. This corresponds to a year-on-year *(YoY) decline of 54.23 per cent.
Profit Before Tax
Profit Before Tax stands at ₹553.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 177.07 per cent from ₹199.70 crore. This corresponds to a year-on-year *(YoY) decline of 70.96 per cent.
Net Profit
Net Profit stands at ₹435.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 96.84 per cent from ₹221.30 crore. This represents a 69.10 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Reddys Laboratories Ltd News
Dr Reddys Laboratories Ltd Earnings
- YOY
- QOQ
Dr Reddys Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Reddys Laboratories Ltd Research Reports
Dr Reddys Laboratories Ltd Financial Reports
Dr Reddys Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | 0.27% | 0.14% | 1.46% | -12.54% | -6.10% | -3.92% |
| Cipla | 0.58% | 1.96% | 0.27% | -2.84% | 13.64% | -5.79% |
| Laurus Labs | -1.28% | -0.88% | 5.95% | 33.09% | 98.18% | 140.21% |
| Mankind Pharma | 0.79% | 2.66% | 4.24% | 0.37% | 22.26% | 0.53% |
| Aurobindo Pharma | 0.09% | 0.25% | 6.13% | 11.15% | 31.04% | 57.85% |
| Lupin | -0.61% | -1.65% | -4.84% | -13.39% | -10.70% | 8.56% |
| Glenmark Pharma. | -2.76% | -3.08% | -2.68% | 8.61% | 9.40% | 20.51% |
Company Info
Company Information
Chairman & Exec. Director : Satish Reddy
Co-Chairman & Managing Director : G V Prasad
Independent Non Exe. Director : Leo Puri
Independent Non Exe. Director : Shikha Sharma
Independent Non Exe. Director : KODUMUDI PRANATHARTHIHARAN KRISHNAN
Independent Non Exe. Director : Pennv Wan
Independent Non Exe. Director : Arun M. Kumar
Independent Non Exe. Director : Claudio Albrecht
Independent Non Exe. Director : ALPNA HANSRAJ SETH
Independent Non Exe. Director : Sanjiv Mehta
Independent Non Exe. Director : Srikanth Ramakrishna Velamakanni
CS / CO / Head - CSR : K Randhir Singh